CW February 2010
Volume 19Issue Number 2 February 2010 ISSN 1059380 AML Survival Influenced by Mutational Status, Cytogenetics, and Patient AgeThe outcome of therapy in patients with acute myeloid leukemia is mainly determined by chromosomal and molecular abnormalities and by older age, according to the results of a long-term, prospective German trial.
Sources and Additional Reading: Thomas Buchner of University of Münster, Münster, Germany, at the American Society of Hematology annual meeting Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW February 2010Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
